DE60207288T2 - Gewebespezifische fluoreszierende chelate - Google Patents

Gewebespezifische fluoreszierende chelate Download PDF

Info

Publication number
DE60207288T2
DE60207288T2 DE60207288T DE60207288T DE60207288T2 DE 60207288 T2 DE60207288 T2 DE 60207288T2 DE 60207288 T DE60207288 T DE 60207288T DE 60207288 T DE60207288 T DE 60207288T DE 60207288 T2 DE60207288 T2 DE 60207288T2
Authority
DE
Germany
Prior art keywords
tetraazacyclododecane
preparation
chelate
composition
europium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60207288T
Other languages
German (de)
English (en)
Other versions
DE60207288D1 (de
Inventor
E. Garry KIEFER
J. Darryl BORNHOP
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Texas Tech University
Dow Global Technologies LLC
Original Assignee
Texas Tech University
Dow Global Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas Tech University, Dow Global Technologies LLC filed Critical Texas Tech University
Publication of DE60207288D1 publication Critical patent/DE60207288D1/de
Application granted granted Critical
Publication of DE60207288T2 publication Critical patent/DE60207288T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60207288T 2001-10-22 2002-10-22 Gewebespezifische fluoreszierende chelate Expired - Fee Related DE60207288T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35568401P 2001-10-22 2001-10-22
US355684P 2001-10-22
PCT/US2002/034242 WO2003035655A1 (en) 2001-10-22 2002-10-22 Tissue specific fluorescent chelates

Publications (2)

Publication Number Publication Date
DE60207288D1 DE60207288D1 (de) 2005-12-15
DE60207288T2 true DE60207288T2 (de) 2006-05-18

Family

ID=23398394

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60207288T Expired - Fee Related DE60207288T2 (de) 2001-10-22 2002-10-22 Gewebespezifische fluoreszierende chelate

Country Status (6)

Country Link
US (1) US6962690B2 (cg-RX-API-DMAC7.html)
EP (1) EP1438318B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005507005A (cg-RX-API-DMAC7.html)
AT (1) ATE309254T1 (cg-RX-API-DMAC7.html)
DE (1) DE60207288T2 (cg-RX-API-DMAC7.html)
WO (1) WO2003035655A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005049096A2 (en) * 2003-11-14 2005-06-02 Dow Global Technologies Inc. Protein and polymer conjugates as chelants with enhanced blood retention
DE102004022628A1 (de) * 2004-05-07 2005-12-15 Sensient Imaging Technologies Gmbh FRET-Bioassay
US20060210479A1 (en) * 2004-08-10 2006-09-21 Dow Global Technologies Inc. Targeting chelants and chelates
WO2006026038A1 (en) * 2004-08-26 2006-03-09 Mallinckrodt Inc. Luminescent metal complexes for monitoring renal function
EP1885817B1 (en) * 2005-05-11 2016-05-11 University Of Durham Responsive luminescent lanthanide complexes
DK1885817T3 (en) 2005-05-11 2016-08-22 Univ Durham Luminescent lanthanide OF RESPONSE
GB0613823D0 (en) 2006-07-12 2006-08-23 Univ Durham Assay
US7996068B2 (en) * 2007-03-14 2011-08-09 The Board Of Trustees Of The Leland Stanford Junior University Surgical method and apparatus for identification of fluorescence
WO2009039466A1 (en) 2007-09-20 2009-03-26 Vanderbilt University Free solution measurement of molecular interactions by backscattering interferometry
US20100036260A1 (en) 2008-08-07 2010-02-11 Remicalm Llc Oral cancer screening device
WO2011156713A1 (en) 2010-06-11 2011-12-15 Vanderbilt University Multiplexed interferometric detection system and method
US9562853B2 (en) 2011-02-22 2017-02-07 Vanderbilt University Nonaqueous backscattering interferometric methods
US9273949B2 (en) 2012-05-11 2016-03-01 Vanderbilt University Backscattering interferometric methods
WO2016118812A1 (en) 2015-01-23 2016-07-28 Vanderbilt University A robust interferometer and methods of using same
EP3408649B1 (en) 2016-01-29 2023-06-14 Vanderbilt University Free-solution response function interferometry

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8502573D0 (sv) 1985-05-23 1985-05-23 Jouko Kanakre Fluorescent lanthanide chelates useful as labels of physiologically active materials
US4976950A (en) 1988-12-19 1990-12-11 The Dow Chemical Company Bone marrow suppressing agents
US5312922A (en) 1992-04-06 1994-05-17 Nordion International Inc. Europium and terbium chelators for time-resolved fluorometric assays
US5714604A (en) 1993-05-06 1998-02-03 The Dow Chemical Company Process for the preparation of azamacrocyclic or acyclic aminophosphonate ester derivatives
US5462725A (en) * 1993-05-06 1995-10-31 The Dow Chemical Company 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
ATE254129T1 (de) 1996-04-19 2003-11-15 Dow Global Technologies Inc Fluoreszierende chelate als gewebespezifische bildgebende mittel
WO2003020701A2 (en) * 2001-09-04 2003-03-13 Texas Tech University Multi-use multimodal imaging chelates

Also Published As

Publication number Publication date
US20030099598A1 (en) 2003-05-29
WO2003035655A1 (en) 2003-05-01
US6962690B2 (en) 2005-11-08
EP1438318B1 (en) 2005-11-09
ATE309254T1 (de) 2005-11-15
JP2005507005A (ja) 2005-03-10
DE60207288D1 (de) 2005-12-15
EP1438318A1 (en) 2004-07-21

Similar Documents

Publication Publication Date Title
EP1184377B1 (en) Hepatobiliary magnetic resonance contrast agents
DE69730820T2 (de) Polyazomacrocyclofluoromonoalkylphosphensäure, ihre komplexe zur verwendung als kontrastmittel
US6277841B1 (en) Quinoline ligands and metal complexes for diagnosis and therapy
US5928627A (en) Fluorescent chelates as visual tissue specific imaging agents
CN108368067B (zh) 二聚造影剂
KR102703312B1 (ko) 조영제
EP1438318B1 (en) Tissue specific fluorescent chelates
US9783554B2 (en) Lanthanide ion complexes and imaging method
DE69921151T2 (de) Fluorszierende marker
EP3774803A1 (en) Pyclen-based macrocyclic ligands, chelates thereof and uses thereof
DE10002939C1 (de) Paramagnetische DOTA-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung für die Herstellung von pharmazeutischen Mitteln
KR20190091441A (ko) 다이머 조영제
EP1170021A2 (de) Konjugate von Peptiden und Lanthanid-Chelaten für die Fluoreszenzdiagnostik
WO2000005235A1 (de) Paramagnetische 3-,8-substituierte deuteroporphyrinderivate, diese enthaltende pharmazeutische mittel, verfahren zu ihrer herstellung und ihre verwendung für das nekrose- und infarkt-mr-imaging
US6559330B1 (en) Calcium complex of [[(4r)-4-[bis{carboxy-.kappa.o)methyl]amino-.kappa.n]-6,9-bis[(carboxy.kappa.o)methyl]-1-[(4,4-diphenylcyclohexyl)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-ylic-acid-.kappa.n6,.kappa.n9,.kappa.011]1-oxidato(6-)]-, hexahydrogen, its salts, pharmaceutical agents that contain these complexes, their use in treatment and as additives in diagnosis, as well as processes for the production of the complexes and agents
AU2002336663A1 (en) Tissue specific fluorescent chelates
AU783982B2 (en) Calcium complex of phosphorus containing ethylenediamine derivatives
US20030203879A1 (en) Calcium complex of [[(4R)-4-[bis[(carboxy-.kappa.O)methyl]amino-.kappa.n]-6,9-bis[(carboxy.kappa.O)methyl]-1-[(4,4-diphenylcyclohexy)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-ylic-acid-.kappa.N6,.Kappa.N9,.Kappa 011]1-oxidato(6-)]-, hexahydrogen, its salts, pharmaceutical agents that contain these complexes, their use in treatment and as additives in diagnosis, as well as processes for the production of the complexes and agents
HK1257515B (en) Dimeric contrast agents
HK1257515A1 (en) Dimeric contrast agents

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee